HPVC2019-058 Pharmaceutical Products and IV Fluids

Current Contract

Contract Start Date
30 Jan 2020
Contract End Date
29 Jan 2024
Option Periods
1 x 2 Year

Description

Contract for the provision of a range of pharmaceutical products and intravenous fluids to Victorian Public Health Services.

Additional Information

Update: 14 September 2023 

Title: HPVITS2019-058.015 Pharmaceutical Products and IV Fluids Supplementary 15 

HSV has made an update to Supplementary 015. Please find the updated information as below:  

Tentative dates: 
 
Announcement of outcome to suppliers: 7 September 2023
 
Announcement of outcome to health services: 18 September 2023
 
Contract Commencement Date: 29 September 2023
 
Scope: 

SUBCATEGORY NUMBER

SUBCATEGORY NAME

551.01

BENDAMUSTINE 100 MG INJECTION, AMPOULE/VIAL

551.02

BENDAMUSTINE 25 MG INJECTION, AMPOULE/VIAL

531.01

BIVALIRUDIN 250MG INJECTION. AMPOULE/VIAL

89.03

CEFAZOLIN 2 G INJECTION, AMPOULE/VIAL

552.01

CYTARABINE 2000 MG/20 ML INJECTION, AMPOULE/VIAL 20 ML

127.01

DEXAMETHASONE PHOSPHATE 4 MG/ML INJECTION, AMPOULE/VIAL 1 ML

127.02

DEXAMETHASONE PHOSPHATE 8 MG/2 ML INJECTION, AMPOULE/VIAL 2 ML

553.01

FOSAPREPITANT 150 MG INJECTION, AMPOULE/VIAL

554.01

GLYCOPYRRONIUM BROMIDE (GLYCOPYRROLATE) 0.5 MG + NEOSTIGMINE 2.5 MG INJECTION, AMPOULE/VIAL 1 ML

300.11

MESALAZINE 1.2G PROLONGED RELEASE TABLET

335.01

NEBIVOLOL 1.25 MG TABLET 28

335.02

NEBIVOLOL 10 MG TABLET 28

335.03

NEBIVOLOL 5 MG TABLET 28

555.01

SACUBITRIL 24.3 MG + VALSARTAN 25.7 MG TABLET 56

555.02

SACUBITRIL 48.6 MG + VALSARTAN 51.4 MG TABLET 56

555.03

SACUBITRIL 97.2 MG + VALSARTAN 102.8 MG TABLET 56

443.01

SITAGLIPTIN 100 MG TABLET 28

443.02

SITAGLIPTIN 25 MG TABLET 28

443.03

SITAGLIPTIN 50 MG TABLET 28

 
All enquiries regarding this supplementary tender should be directed to s.saw@healthsharevic.org.au or (03) 9947 3935. 
 

 

Title: HPVITS2019-058.016 Pharmaceutical Products and IV Fluids Supplementary 16

HSV has made an update to Supplementary 016. Please find the updated information as below:

Upcoming Supplementary Tender

Supplier Briefing Date: 20 September 2023

Request For Information Market Release Date: 28 September 2023
Request For Information Market Closing Date: 27 October 2023 14:00 AEDT

Request For Quotation Market Release Date: 20 November 2023
Request For Quotation Market Closing Date: 29 November 2023 14:00 AEDT

Scope:

Subcategory number

Subcategory name

556.01

SUGAMMADEX 200 MG/2 ML INJECTION, AMPOULE/VIAL 2 ML

556.02

SUGAMMADEX 500 MG/5 ML INJECTION, AMPOULE/VIAL 5 ML


All enquiries regarding this supplementary tender prior to the market release date should be directed to s.saw@healthsharevic.org.au or (03) 9947 3935. Once the tender has been released, please direct all correspondence through the HSV Procurement Portal.

Tentative dates:

Announcement of outcome to suppliers: 8 December 2023

Announcement of outcome to health services: 15 December 2023

Contract Commencement Date: 15 December 2023

Transition Period Post Contract Commencement: 4 weeks

 

Title: HPVOPT2019-058 Pharmaceutical Products and IV Fluids Option Review 

HSV is currently engaging incumbents of the HPVC2019-058 contract as part of the Option period review. 

Useful information:
1. To subscribe and receive contract update notifications, favourite this contract cabinet.
2. Review your account settings to ensure the notification frequency selected is adequate.
3. Information for Prospective Suppliers can be found on our website: https://healthsharevic.org.au/tenders-and-contracts/information-for-new-suppliers/prospective-suppliers/



Categories

Category 1 - Pharmaceutical Products
Category 50,000 - Intravenous Fluids
Category 60,000 - Parenteral Nutrition Solutions
Category 70,000 - Irrigating Solutions
Category 80,000 - Biopharmaceuticals
Category 90,000 – Therapeutic Group Approach